🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
313,52 USD
Máx. histórico
322,75
4 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-2,86%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,12%
Cierre anterior
307,02
Rango de hoy
309,46 – 317,76
Volumen hoy
195.564
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 33,04 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 12 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 18/03/2024 | 71,20 | 73,65 | 70,03 | 72,14 | +1,48% | 5,08% | 182.500 |
| 15/03/2024 | 71,43 | 72,19 | 69,84 | 71,09 | -1,17% | 3,29% | 1.219.400 |
| 14/03/2024 | 72,72 | 73,91 | 71,45 | 71,93 | -1,14% | 3,38% | 205.500 |
| 13/03/2024 | 72,44 | 74,04 | 72,21 | 72,76 | +0,55% | 2,53% | 143.000 |
| 12/03/2024 | 72,52 | 72,59 | 71,06 | 72,36 | +0,15% | 2,11% | 129.100 |
| 11/03/2024 | 73,65 | 73,80 | 71,83 | 72,25 | -2,06% | 2,67% | 116.300 |
| 08/03/2024 | 73,06 | 75,31 | 72,28 | 73,77 | +1,79% | 4,15% | 191.500 |
| 07/03/2024 | 72,96 | 74,97 | 72,47 | 72,47 | -0,33% | 3,43% | 141.200 |
| 06/03/2024 | 74,65 | 74,75 | 71,72 | 72,71 | -1,74% | 4,06% | 179.100 |
| 05/03/2024 | 75,71 | 76,88 | 72,35 | 74,00 | -2,99% | 5,98% | 218.000 |
| 04/03/2024 | 78,75 | 78,75 | 75,41 | 76,28 | -3,07% | 4,24% | 185.500 |
| 01/03/2024 | 80,05 | 80,94 | 77,07 | 78,70 | -0,82% | 4,83% | 173.000 |
| 29/02/2024 | 85,06 | 85,06 | 75,83 | 79,35 | -5,93% | 10,85% | 327.700 |
| 28/02/2024 | 88,28 | 89,88 | 82,22 | 84,35 | -5,44% | 8,68% | 436.700 |
| 27/02/2024 | 85,18 | 94,57 | 80,00 | 89,20 | +19,86% | 17,10% | 796.900 |
| 26/02/2024 | 75,15 | 75,95 | 73,94 | 74,42 | -1,91% | 2,67% | 91.800 |
| 23/02/2024 | 74,00 | 75,87 | 72,29 | 75,87 | +3,14% | 4,84% | 103.600 |
| 22/02/2024 | 72,44 | 74,00 | 71,71 | 73,56 | +1,22% | 3,16% | 94.600 |
| 21/02/2024 | 71,94 | 72,67 | 71,47 | 72,67 | +0,41% | 1,67% | 117.200 |
| 20/02/2024 | 72,81 | 73,74 | 72,25 | 72,37 | -1,75% | 2,05% | 94.000 |
| 16/02/2024 | 74,30 | 75,11 | 73,55 | 73,66 | -1,33% | 2,10% | 108.600 |
| 15/02/2024 | 74,32 | 75,45 | 73,11 | 74,65 | +1,40% | 3,15% | 122.400 |
| 14/02/2024 | 71,77 | 73,94 | 71,57 | 73,62 | +3,69% | 3,30% | 154.000 |
| 13/02/2024 | 73,34 | 74,75 | 70,58 | 71,00 | -6,13% | 5,69% | 154.200 |
| 12/02/2024 | 76,19 | 76,90 | 75,41 | 75,64 | -0,32% | 1,96% | 95.800 |
| 09/02/2024 | 75,05 | 76,95 | 74,60 | 75,88 | +0,62% | 3,13% | 111.100 |
| 08/02/2024 | 73,98 | 75,55 | 73,98 | 75,41 | +1,21% | 2,12% | 176.800 |
| 07/02/2024 | 75,11 | 75,11 | 74,07 | 74,51 | -1,06% | 1,38% | 122.400 |
| 06/02/2024 | 74,22 | 75,76 | 73,42 | 75,31 | +0,79% | 3,15% | 179.100 |
| 05/02/2024 | 74,21 | 75,32 | 73,30 | 74,72 | +0,24% | 2,72% | 78.600 |